Convergent molecular mechanisms underlying cognitive impairment in mucopolysaccharidosis type II

Area of Science:

• Genetics and Molecular Biology
• Neuroscience
• Biochemistry

Background:

• Mucopolysaccharidosis type II (MPS II) is a lysosomal storage disorder resulting from IDS gene variants.
• Deficiency in iduronate-2-sulfatase leads to glycosaminoglycan accumulation, particularly affecting the central nervous system.
• Neuronopathic MPS II presents with cognitive impairment, behavioral issues, and developmental regression.

Purpose of the Study:

• To investigate the role of axon guidance instability in cognitive impairment in MPS II.
• To identify novel candidate genes and pathways contributing to neurodevelopmental defects in MPS II.
• To uncover potential molecular targets for early diagnosis and therapeutic development.

Main Methods:

• Utilized brain expression data, network propagation, and clustering algorithms.
• Analyzed the human interactome to prioritize a disease module associated with MPS II.
• Focused on pathways including focal adhesion, integrin cell surface, and cytoskeleton.

Main Results:

• Identified candidate genes and pathways implicated in neural circuit formation defects.
• Highlighted molecular mechanisms in focal adhesion, cell surface interactions, and ECM proteoglycans.
• Revealed potential links between early molecular changes and cognitive impairment in MPS II.

Conclusions:

• Early molecular alterations during neurodevelopment may precede clinical manifestations of MPS II.
• The identified pathways offer insights into cognitive deficits and suggest targets for drug development.
• Findings support shared pathogenic mechanisms between MPS II and other neurodegenerative diseases.